Ami Bavishi
Investor Relations Contact en RALLYBIO CORPORATION .
Perfil
Ami Bavishi is currently the Head of Investor Relations & Corporate Communications at Rallybio Corp.
Prior to this, he worked as the Director of Investor Relations at Aerie Pharmaceuticals, Inc. Mr. Bavishi has a graduate degree from George Washington University and an undergraduate degree from Duquesne University of The Holy Spirit.
Cargos activos de Ami Bavishi
| Empresas | Cargo | Inicio |
|---|---|---|
| RALLYBIO CORPORATION | Investor Relations Contact | 18/01/2022 |
Antiguos cargos conocidos de Ami Bavishi.
| Empresas | Cargo | Fin |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Formación de Ami Bavishi.
| George Washington University | Graduate Degree |
| Duquesne University of The Holy Spirit | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| RALLYBIO CORPORATION | Health Technology |
| Empresas privadas | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Ami Bavishi
